<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR941028-2-00162</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4703 -->  <!-- PJG ITAG l=74 g=1 f=1 --> Contents <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=1 --> Executive Summary <!-- PJG 0012 frnewline --> I. Introduction <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=1 --> A. Purpose of Document <!-- PJG 0012 frnewline --> B. Epidemiology, Transmission, and Pathogenesis of TB <!-- PJG 0012 frnewline --> C. Risk for Nosocomial Transmission of  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=3 --> M. tuberculosis <!-- PJG 0012 frnewline --> D. Fundamentals of TB Infection Control <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=3 --> II. Recommendations <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=3 --> A. Assignment of Responsibility <!-- PJG 0012 frnewline --> B. Risk Assessment, Development of the TB Infection-Control Plan, and Periodic Reassessment <!-- PJG 0012 frnewline --> 1. Risk assessment <!-- PJG 0012 frnewline --> a. General <!-- PJG 0012 frnewline --> b. Community TB profile <!-- PJG 0012 frnewline --> c. Case surveillance <!-- PJG 0012 frnewline --> d. Analysis of HCW PPD test screening data <!-- PJG 0012 frnewline --> e. Review of TB patient medical records <!-- PJG 0012 frnewline --> f. Observation of TB infection-control practices <!-- PJG 0012 frnewline --> g. Engineering evaluation <!-- PJG 0012 frnewline --> 2. Development of the TB Infection-Control Plan <!-- PJG 0012 frnewline --> 3. Periodic Reassessment <!-- PJG 0012 frnewline --> 4. Examples of Risk Assessment <!-- PJG 0012 frnewline --> C. Identifying, Evaluating, and Initiating Treatment for Patients Who May Have Active TB <!-- PJG 0012 frnewline --> 1. Identifying patients who may have active TB <!-- PJG 0012 frnewline --> 2. Diagnostic evaluation for active TB <!-- PJG 0012 frnewline --> 3. Initiation of treatment for suspected or confirmed TB <!-- PJG 0012 frnewline --> D. Management of Patients Who May Have Active TB in Ambulatory-Care Settings and Emergency Departments <!-- PJG 0012 frnewline --> E. Management of Hospitalized Patients Who Have Confirmed or Suspected TB <!-- PJG 0012 frnewline --> 1. Initiation of isolation for TB <!-- PJG 0012 frnewline --> 2. TB isolation practices <!-- PJG 0012 frnewline --> 3. The TB isolation room <!-- PJG 0012 frnewline --> 4. Discontinuation of TB isolation <!-- PJG 0012 frnewline --> 5. Discharge planning <!-- PJG 0012 frnewline --> F. Engineering Control Recommendations <!-- PJG 0012 frnewline --> 1. General ventilation <!-- PJG 0012 frnewline --> 2. Additional engineering control approaches <!-- PJG 0012 frnewline --> a. HEPA filtration <!-- PJG 0012 frnewline --> b. UVGI <!-- PJG 0012 frnewline --> G. Respiratory Protection <!-- PJG 0012 frnewline --> H. Cough-Inducing and Aerosol-Generating Procedures <!-- PJG 0012 frnewline --> 1. General guidelines <!-- PJG 0012 frnewline --> 2. Special considerations for bronchoscopy <!-- PJG 0012 frnewline --> 3. Special considerations for the administration of aerosolized pentamidine <!-- PJG 0012 frnewline --> I. Education and Training of HCWs <!-- PJG 0012 frnewline --> J. HCW Counseling, Screening, and Evaluation <!-- PJG 0012 frnewline --> 1. Counseling HCWs regarding TB <!-- PJG 0012 frnewline --> 2. Screening HCWs for active TB <!-- PJG 0012 frnewline --> 3. Screening HCWs for latent TB infection <!-- PJG 0012 frnewline --> 4. Evaluation and management of HCWs who have positive PPD test results or active TB <!-- PJG 0012 frnewline --> a. Evaluation <!-- PJG 0012 frnewline --> b. Routine and follow-up chest radiographs <!-- PJG 0012 frnewline --> c. Workplace restrictions <!-- PJG 0012 frnewline --> (1) Active TB <!-- PJG 0012 frnewline --> (2) Latent TB infection <!-- PJG 0012 frnewline --> K. Problem Evaluation <!-- PJG 0012 frnewline --> 1. Investigating PPD test conversions and active TB in HCWs <!-- PJG 0012 frnewline --> a. Investigating PPD test conversions in HCWs <!-- PJG 0012 frnewline --> b. Investigating cases of active TB in HCWs <!-- PJG 0012 frnewline --> 2. Investigating possible patient-to-patient transmission of M. tuberculosis <!-- PJG 0012 frnewline --> 3. Investigating contacts of patients and HCWs who have infectious TB <!-- PJG 0012 frnewline --> L. Coordination with the Public Health Department <!-- PJG 0012 frnewline --> M. Additional Considerations for Selected Areas in Health-Care Facilities and Other Health-Care settings <!-- PJG 0012 frnewline --> 1. Selected areas in health-care facilities <!-- PJG 0012 frnewline --> a. Operating rooms <!-- PJG 0012 frnewline --> b. Autopsy rooms <!-- PJG 0012 frnewline --> c. Laboratories <!-- PJG 0012 frnewline --> 2. Other health-care settings <!-- PJG 0012 frnewline --> a. Emergency medical services <!-- PJG 0012 frnewline --> b. Hospices <!-- PJG 0012 frnewline --> c. Long-term care facilities <!-- PJG 0012 frnewline --> d. Correctional facilities <!-- PJG 0012 frnewline --> e. Dental settings <!-- PJG 0012 frnewline --> f. Home-health-care settings <!-- PJG 0012 frnewline --> g. Medical offices <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=3 --> Supplement 1: Determining the Infectiousness of a TB Patient <!-- PJG 0012 frnewline --> Supplement 2: Diagnosis and Treatment of Latent TB Infection and Active TB <!-- PJG 0012 frnewline --> I. Diagnostic Procedures for TB Infection and Disease <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=3 --> A. PPD Skin Testing and Anergy Testing <!-- PJG 0012 frnewline --> 1. Application and reading of PPD skin tests <!-- PJG 0012 frnewline --> 2. Interpretation of PPD skin tests <!-- PJG 0012 frnewline --> a. General <!-- PJG 0012 frnewline --> b. HCWs <!-- PJG 0012 frnewline --> 3. Anergy testing <!-- PJG 0012 frnewline --> 4. Pregnancy and PPD skin testing <!-- PJG 0012 frnewline --> 5. BCG vaccination and PPD skin testing <!-- PJG 0012 frnewline --> 6. The booster phenomenon <!-- PJG 0012 frnewline --> B. Chest Radiography <!-- PJG 0012 frnewline --> C. Bacteriology <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=3 --> II. Preventive Therapy for Latent TB Infection and Treatment of Active TB <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=3 --> A. Preventive Therapy for Latent TB Infection <!-- PJG 0012 frnewline --> B. Treatment of Patients Who Have Active TB <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=3 --> Supplement 3: Engineering Controls <!-- PJG 0012 frnewline --> I. Introduction <!-- PJG 0012 frnewline --> II. Ventilation <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=3 --> A. Local Exhaust Ventilation <!-- PJG 0012 frnewline --> 1. Enclosing devices <!-- PJG 0012 frnewline --> 2. Exterior devices <!-- PJG 0012 frnewline --> 3. Discharge exhaust from booths, tents, and hoods <!-- PJG 0012 frnewline --> B. General Ventilation <!-- PJG 0012 frnewline --> 1. Dilution and removal <!-- PJG 0012 frnewline --> a. Types of general ventilation systems <!-- PJG 0012 frnewline --> b. Ventilation rates <!-- PJG 0012 frnewline --> 2. Airflow patterns within rooms (air mixing) <!-- PJG 0012 frnewline --> 3. Airflow direction in the facility <!-- PJG 0012 frnewline --> a. Directional airflow <!-- PJG 0012 frnewline --> b. Negative pressure for achieving directional airflow <!-- PJG 0012 frnewline --> 4. Achieving negative pressure in a room <!-- PJG 0012 frnewline --> a. Pressure differential <!-- PJG 0012 frnewline --> b. Alternate methods for achieving negative pressure <!-- PJG 0012 frnewline --> c. Monitoring negative pressure <!-- PJG 0012 frnewline --> C. HEPA filtration <!-- PJG 0012 frnewline --> 1. Use of HEPA filtration when exhausting air to the outside <!-- PJG 0012 frnewline --> 2. Recirculation of HEPA-filtered air to other areas of a facility <!-- PJG 0012 frnewline --> 3. Recirculation of HEPA-filtered air within a room <!-- PJG 0012 frnewline --> a. Fixed room-air recirculation systems <!-- PJG 0012 frnewline --> b. Portable room-air recirculation units <!-- PJG 0012 frnewline --> c. Evaluation of room-air recirculation systems and units <!-- PJG 0012 frnewline --> 4. Installing, maintaining, and monitoring HEPA filters <!-- PJG 0012 frnewline --> D. TB Isolation Rooms and Treatment Rooms <!-- PJG 0012 frnewline --> 1. Preventing the escape of droplet nuclei from the room <!-- PJG 0012 frnewline --> 2. Reducing the concentration of droplet nuclei in the room <!-- PJG 0012 frnewline --> 3. Exhaust from TB isolation rooms and treatment rooms <!-- PJG 0012 frnewline --> 4. Alternatives to TB isolation rooms <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=3 --> III. UVGI <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=3 --> A. Applications <!-- PJG 0012 frnewline --> 1. Duct irradiation <!-- PJG 0012 frnewline --> 2. Upper-room air irradiation <!-- PJG 0012 frnewline --> B. Limitations <!-- PJG 0012 frnewline --> C. Safety Issues <!-- PJG 0012 frnewline --> D. Exposure Criteria for UV Radiation <!-- PJG 0012 frnewline --> E. Maintenance and Monitoring <!-- PJG 0012 frnewline --> 1. Labelling and posting <!-- PJG 0012 frnewline --> 2. Maintenance <!-- PJG 0012 frnewline --> 3. Monitoring <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=3 --> Supplement 4: Respiratory Protection <!-- PJG 0012 frnewline --> I. Considerations for Selection of Respirators <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=3 --> A. Performance Criteria for Personal Respirators for Protection Against Transmission of M. tuberculosis <!-- PJG 0012 frnewline --> B. Specific Respirators <!-- PJG 0012 frnewline --> C. The Effectiveness of Respiratory Protective Devices <!-- PJG 0012 frnewline --> 1. Face-seal leakage <!-- PJG 0012 frnewline --> 2. Filter leakage <!-- PJG 0012 frnewline --> 3. Fit testing <!-- PJG 0012 frnewline --> 4. Fit checking <!-- PJG 0012 frnewline --> 5. Reuse of respirators <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=3 --> II. Implementing a Personal Respiratory Protection Program <!-- PJG 0012 frnewline --> Supplement 5: Decontamination_Cleaning, Disinfecting, and Sterilizing of Patient-Care Equipment <!-- PJG 0012 frnewline --> References <!-- PJG 0012 frnewline --> Glossary <!-- PJG 0012 frnewline --> Index <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=3 --> List of Tables <!-- PJG 0012 frnewline --> List of Figures <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            